ArticleFrontiers in oncology2022

Case report: Clinical success targeting BRAF-mutated, hormone receptor positive, HER2- negative advanced breast cancer patient with BRAF-inhibitor plus MEK- inhibitor.

Alfonso López de Sá et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.